Genomics specialist Geneservice announces management buyout from the Medical Research Council
The current management of genomics specialist MRC geneservice announced it had reached agreement with the UK MRC over a management buyout. The assets and majority of staff of MRC geneservice will be transferred into a new company Geneservice Ltd on August 1st 2005 to be based on the Cambridge Science Park. Under a transitional services agreement however, Geneservice has commenced trading, taking new orders and promoting itself with immediate effect. Geneservice will operate as a genomic reagents provider and continue to offer existing services that include sequencing, genotyping, microarray Expression analysis and whole genome amplification.
Geneservice will inherit from the MRC more than 10 years pedigree as a biological resource centre and innovative genomics services provider. The company will occupy a unique position, rapidly identifying potential services and products arising from the multitude of genomics projects worldwide and making them available to the genomic research community. A wide international customer base including leading research centres and pharmaceutical companies has already been built. Geneservice's one-stop service for genomics researchers is highly regarded for its quality, turnaround time and competitive pricing. The continuing mission of Geneservice will be to provide an archiving and distribution portal for emerging genomic reagents, such as bacterial clones and Human DNA samples, generated by academic groups and consortia internationally. The new entity will also provide access to state-of-the-art high throughput technologies for the study of gene expression and gene mapping, including disease gene identification. Likewise, the initial product portfolio includes genomic clones from a wide range of organisms in various formats. The Geneservice range of services includes DNA sequencing, micro satellite and SNP genotyping, whole genome amplification and RNA expression profiling.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.